Evidence map›Paper›PMID 38563381›Full record

ArticleJournal of the American Heart Association2024

Two-Week Interruption of Statin Therapy Results in an Exaggerated Inflammatory Monocyte Phenotype in Young Patients With Myocardial Infarction Without Standard Modifiable Risk Factors.

Jan-Quinten Mol, Julia van Tuijl, Siroon Bekkering, Laura Rodwell, Gheorghe A M Pop, Mihai G Netea, Niels van Royen, Niels P Riksen, Saloua El Messaoudi

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jan-Quinten MolDepartment of Cardiology Radboud University Medical Center Nijmegen the Netherlands.ORCID 0000-0002-8609-1550
Julia van TuijlDepartment of Internal Medicine Radboud University Medical Center Nijmegen the Netherlands.ORCID 0000-0001-8042-6121
Siroon BekkeringDepartment of Internal Medicine Radboud University Medical Center Nijmegen the Netherlands.ORCID 0000-0003-1149-466X
Laura RodwellSection Biostatistics, Department for Health Evidence Radboud Institute for Health Sciences, Radboud University Medical Center Nijmegen the Netherlands.
Gheorghe A M PopDepartment of Cardiology Radboud University Medical Center Nijmegen the Netherlands.ORCID 0000-0002-9331-0870
Mihai G NeteaDepartment of Internal Medicine Radboud University Medical Center Nijmegen the Netherlands.ORCID 0000-0003-2421-6052
Niels van RoyenDepartment of Cardiology Radboud University Medical Center Nijmegen the Netherlands.ORCID 0000-0001-6136-8640
Niels P RiksenDepartment of Internal Medicine Radboud University Medical Center Nijmegen the Netherlands.ORCID 0000-0001-9197-8124
Saloua El MessaoudiDepartment of Cardiology Radboud University Medical Center Nijmegen the Netherlands.ORCID 0009-0006-0804-2071

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsMyocardial InfarctionHumansMonocytesPhenotypeRisk FactorsHydroxymethylglutaryl-CoA Reductase Inhibitorsinflammationmonocytesmyocardial infarctionstandard modifiable risk factorsstatins

Identifiers

PMID38563381
PMCPMC11262512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.